Venus Concept (VERO) Prices 11.25M Common Share Offering at $2/Sh

Venus Concept Inc. (NASDAQ: VERO), a global medical aesthetic technology leader, today announced the pricing of its public offering of 11,250,000 shares of its common stock and warrants to purchase 5,625,000 shares of common stock at a combined offering price to the public of $2.00 per share and accompanying warrant. The warrants have an exercise price of $2.50 per share of common stock, are exercisable immediately, and expire five years from the date of issuance. Venus Concept intends to use the gross proceeds of approximately $22.5 million, before deducting underwriting discounts and commissions and estimated offering expenses, from the offering for general corporate purposes, including the funding of research and development activities.

Oppenheimer & Co. Inc. is acting as sole book-running manager and Ladenburg Thalmann & Co. Inc. is acting as lead manager of the proposed offering.

The offering will be made only by means of a written prospectus and related prospectus supplement forming part of a shelf registration statement on Form S-3 (No. 333-228562) that was initially filed with the U.S. Securities and Exchange Commission (the "SEC") on November 27, 2018 and declared effective on December 10, 2018.

You May Also Be Interested In

• Saratoga Investment Corp. launches unsecured notes offering on NYSE
• Precision Optics names Peter Thier as SVP of sales and marketing
• AirJoule to test heat-to-water system at data center site in 2026